Jae-Seung Kim

Director/Miembro de la Junta en QURIENT CO., LTD. .

Fortuna: 546 524 $ al 31/05/2024

56 años

Health Technology

Consumer Services

Perfil

Jae-Seung Kim is currently the Director & Head-Research Center at Qurient Co., Ltd.
Previously, he worked as the Communications Director at Institut Pasteur Korea Research Foundation.
He holds a doctorate degree from The State University of New York.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
QURIENT CO., LTD. 0.66%	19/12/2023	178 675 ( 0.66% )	546 524 $	31/05/2024

Cargos activos de Jae-Seung Kim

Empresas	Cargo	Inicio
QURIENT CO., LTD.	Director/Miembro de la Junta	-

Todos los cargos activos de Jae-Seung Kim

Antiguos cargos conocidos de Jae-Seung Kim.

Empresas	Cargo	Fin
Institut Pasteur Korea Research Foundation Institut Pasteur Korea Research Foundation BiotechnologyHealth Technology Institut Pasteur Korea Research Foundation provides research and development for the treatment of infectious and chronic diseases. It develops a technology-based approach to therapeutic development through cellular models, high content screening and medicinal chemistry. The company was founded on December 29, 2003 and is headquartered in Seongnam, South Korea.	Contacto de Relaciones con Inversores	-

Ver el detalle de la experiencia de Jae-Seung Kim.

Formación de Jae-Seung Kim.

The State University of New York

Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Jae-Seung Kim.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
QURIENT CO., LTD.	Health Technology

Empresas privadas	1
Institut Pasteur Korea Research Foundation Institut Pasteur Korea Research Foundation BiotechnologyHealth Technology Institut Pasteur Korea Research Foundation provides research and development for the treatment of infectious and chronic diseases. It develops a technology-based approach to therapeutic development through cellular models, high content screening and medicinal chemistry. The company was founded on December 29, 2003 and is headquartered in Seongnam, South Korea.	Health Technology